SCHEMBL16246609

SCHEMBL16246609

CCCCC1C(CO)CCN1C(=O)O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DPP4 P27487 1/20 0.35
▸ GBA2 Q9HCG7 3/20 0.33
▸ POLB P06746 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ GNAI3 P08754 4/20 0.33
▸ GNAO1 P09471 4/20 0.33
▸ GNAI1 P63096 4/20 0.33
▸ CHRM1 P11229 2/20 0.33
▸ CHRM2 P08172 1/20 0.33
▸ CHRM4 P08173 1/20 0.33
▸ HTR1A P08908 1/20 0.33
▸ CHRM5 P08912 1/20 0.33
▸ ADRA2A P08913 1/20 0.33
▸ DRD2 P14416 1/20 0.33
▸ ADRA2B P18089 1/20 0.33
▸ CHRM3 P20309 1/20 0.33
▸ DRD4 P21917 1/20 0.33
▸ ADRA1D P25100 1/20 0.33
▸ ADRA1A P35348 1/20 0.33
▸ HRH1 P35367 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7493150 0.80 GBA2 (0.38) DPP4GBA2POLBHPGDCHRM1
SCHEMBL25289307 0.80 DPP4 (0.41) DPP4GNAI3GNAO1GNAI1
SCHEMBL3392895 0.75 GBA2 (0.35) DPP4GBA2POLBHPGDGNAI3
SCHEMBL18007267 0.74 LSS (0.38) DPP4POLBCOL1A1MAPT
SCHEMBL23527269 0.72 GBA2 (0.35) GBA2POLBHPGDGBA1
SCHEMBL2570899 0.71 ALDH1A1 (0.31) POLBHPGDGNAI3GNAO1GNAI1
SCHEMBL14513315 0.69 CHRNB2 (0.34) DPP4GBA2POLBGBA1MAPT
SCHEMBL5222630 0.69 S1PR3 (0.40) DPP4GNAI3GNAO1GNAI1ALOX5
SCHEMBL26689858 0.69 GBA2 (0.40) GBA2GBA1MAPT
SCHEMBL2435934 0.69 TACR3 (0.40) DPP4POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2999469-A1 PHARMACEUTICAL COMPOSITION AND THE USE THEREOF, AND APPLICATION REGIME OF SAID PHARMACEUTICAL COMPOSITION FOR ON-DEMAND CONTRACEPTION Bayer Pharma Aktiengesellschaft (DE) 2016-03-30 — — EP disclosed
WO-2014187744-A1 PHARMACEUTICAL COMPOSITION AND THE USE THEREOF, AND APPLICATION REGIME OF SAID PHARMACEUTICAL COMPOSITION FOR ON-DEMAND CONTRACEPTION BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2014-11-27 — — WO disclosed
Send feedback